首页> 美国卫生研究院文献>Journal of Zhejiang University. Science. B >Iptakalim an ATP-sensitive potassium channel opener confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells
【2h】

Iptakalim an ATP-sensitive potassium channel opener confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells

机译:ATP敏感性钾通道开放剂伊他卡林通过保护神经血管单位细胞赋予神经保护作用以抵抗大鼠脑缺血/再灌注损伤

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objective: To investigate the role of iptakalim, an ATP-sensitive potassium channel opener, in transient cerebral ischemia/reperfusion (I/R) injury and its involved mechanisms. Methods: Intraluminal occlusion of middle cerebral artery (MCAO) in a rat model was used to investigate the effect of iptakalim at different time points. Infarct volume was measured by staining with 2,3,5-triphenyltetrazolium chloride, and immunohistochemistry was used to evaluate the expressions of Bcl-2 and Bax. In vitro, neurovascular unit (NVU) cells, including rat primary cortical neurons, astrocytes, and cerebral microvascular endothelial cells, were cultured and underwent oxygen-glucose deprivation (OGD). The protective effect of iptakalim on NVU cells was investigated by cell viability and injury assessments, which were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and release of lactate dehydrogenase. Caspase-3, Bcl-2 and Bax mRNA expressions were evaluated by real-time polymerase chain reaction (PCR). Results: Administration of iptakalim 0 or 1 h after reperfusion significantly reduced infarct volumes, improved neurological scores, and attenuated brain edema after cerebral I/R injury. Iptakalim treatment (0 h after reperfusion) also reduced caspase-3 expression and increased the ratio of Bcl-2 to Bax by immunohistochemistry. Iptakalim inhibited OGD-induced cell death in cultured neurons and astrocytes, and lactate dehydrogenase release from cerebral microvascular endothelial cells. Iptakalim reduced mRNA expression of caspase-3 and increased the ratio of Bcl-2 to Bax in NVU cells. Conclusions: Iptakalim confers neuroprotection against cerebral I/R injury by protecting NVU cells via inhibiting of apoptosis.
机译:目的:探讨ATP敏感性钾通道开放剂依他卡林在短暂性脑缺血/再灌注(I / R)损伤中的作用及其相关机制。方法:以大鼠大脑中动脉腔内闭塞(MCAO)为模型,研究伊帕卡林在不同时间点的作用。通过用2,3,5-三苯基四唑氯化物染色来测量梗塞体积,并使用免疫组织化学来评估Bcl-2和Bax的表达。在体外,培养包括大鼠原代皮层神经元,星形胶质细胞和脑微血管内皮细胞在内的神经血管单位(NVU)细胞,并进行氧葡萄糖剥夺(OGD)。通过细胞生存力和损伤评估研究了依他卡林对NVU细胞的保护作用,并通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物和乳酸脱氢酶的释放来测量。通过实时聚合酶链反应(PCR)评估Caspase-3,Bcl-2和Bax mRNA的表达。结果:再灌注后0或1 h给予iptakalim可以显着减少脑I / R损伤后的梗塞体积,改善神经功能评分并减轻脑水肿。依他卡林治疗(再灌注后0小时)还通过免疫组织化学降低了caspase-3的表达并增加了Bcl-2与Bax的比例。依他卡林抑制OGD诱导的培养神经元和星形胶质细胞死亡,并抑制脑微血管内皮细胞释放乳酸脱氢酶。依他卡林可降低NVU细胞中caspase-3的mRNA表达并增加Bcl-2与Bax的比率。结论:埃他卡林通过抑制细胞凋亡来保护NVU细胞,从而赋予神经保护作用以抗脑I / R损伤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号